September 27th, 2023

Micron Technology, Inc. (Nasdaq: MU), a renowned semiconductor company, reported a loss of $(1.07) per share for the fourth quarter of fiscal 2023, better than the consensus estimate loss of $(1.18). The company's quarterly revenues reached $4.01 bil. Read more

September 27th, 2023

Amazon’s ongoing pattern of illegal conduct blocks competition, allowing it to wield monopoly power to inflate prices, degrade quality, and stifle innovation for consumers and businesses Washington D.C. / CRWE PRESS RELEASE / September 26, 2. Read more

September 27th, 2023

UBS has initiated coverage on Blink Charging Co. (Nasdaq: BLNK), a leading provider of electric vehicle charging services, with a Buy rating and a price target of $7. With $BLNK closing at $2.93 on Tuesday, the price target suggests a significant . Read more

September 26th, 2023

Shares of Galecto, Inc. (Nasdaq: GLTO) surged by more than 30% in after-hous trading following the company's announcement of a comprehensive review of its business operations. Galecto aims to explore strategic alternatives focused on maximizing sh. Read more

September 26th, 2023

MillerKnoll, Inc. (Nasdaq: MLKN) reported robust first-quarter fiscal 2024 earnings, coming in at $0.37 per share, surpassing the consensus EPS estimate of $0.21. The company also exceeded revenue expectations, with quarterly sales reaching $917.70 m. Read more

September 26th, 2023

Shares of Soleno Therapeutics, Inc. (Nasdaq: SLNO) soared over 300% in pre-market trading following the release of positive top-line results from Study C602.  The study, which focused on the long-term treatment of Prader-Willi syndrome (PWS) . Read more

September 26th, 2023

Shares of Immunovant, Inc. (Nasdaq: IMVT) surged by more than 40% in pre-market trading after promising Phase 1 trial results for IMVT-1402. Administered subcutaneously in healthy adults, IMVT-1402 demonstrated significant dose-dependent reductions i. Read more

September 26th, 2023

Shares of Profound Medical Corp. (Nasdaq: PROF) surged by more than 10% in after-hours trading after it announced FDA clearance for its Thermal Boost module in conjunction with TULSA-PRO, which allows surgeons to treat various prostate conditions, in. Read more

September 25th, 2023

Shares of Femasys Inc. (Nasdaq: FEMY) surged by over 100% in after-hours trading following the company's announcement of receiving 510(k) Clearance from the United States Food and Drug Administration (FDA) for its groundbreaking infertility treatment. Read more

September 25th, 2023

LAS VEGAS, NV / CRWE PRESS RELEASE / September 25, 2023  -  Crown Equity Holdings, Inc. (OTC PINK:CRWE) today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a pro. Read more